Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Edesa Biotech Inc EDSA

Healthcare Biotechnology
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company developing various ways to treat inflammatory and immune-related diseases. The Company's most advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for acute and chronic disease indications that involve dysregulated innate immune responses. It is evaluating EB05 in a Phase III study as a potential... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:EDSA)

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

GlobeNewswire February 14, 2025

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

GlobeNewswire February 13, 2025

Edesa Biotech Reports Fiscal Year 2024 Results

GlobeNewswire December 13, 2024

Edesa Biotech's Founder Makes Strategic Investment in the Company

GlobeNewswire October 31, 2024

Edesa Biotech Announces Upcoming Conference Schedule

GlobeNewswire October 21, 2024

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

ACCESS Newswire June 24, 2024

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

ACCESS Newswire May 10, 2024

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

ACCESS Newswire April 11, 2024

Edesa Biotech to Participate in Upcoming Investor Conferences

ACCESS Newswire April 2, 2024
View More News ››

Opinion & Analysis (NDAQ:EDSA)

Edesa Shares Double Upon Gaining Approval to Initiate Phase 2/3 COVID-19 Study

Streetwise Reports June 16, 2020

Stellar Biotechnologies (SBOT:NASDAQ) inks multiyear KLH supply agreement with Amaran Biotechnology; Stellar up 13% on news

The Life Sciences Report March 3, 2017

Stellar Biotechnologies (SBOT:NASDAQ) could rise with KLH vaccine trial success

The Life Sciences Report March 2, 2017

Partnerships propel Stellar Biotechnologies' vaccine technology

The Life Sciences Report June 22, 2016
View More Opinion ››

Bullboard Posts (NDAQ:EDSA)

Sold out of this stock today.Wow.

Got out of this one at $3.76 cents per share.
coolfooldumbguy - February 13, 2025

Buy buddy buy because it's taking off this morning.

So good luck   to all of you guys out there.
coolfooldumbguy - February 13, 2025

Using technical analysis for this stock.

This stock is a big bargain for me at these low prices.BUY buddy buy before it is too late for you fellas out there.Wow.
coolfooldumbguy - January 24, 2025

Edesa Biotech, Inc. (NASDAQ:EDSA): A Promising Biopharmaceut

http://beyondspx.com/2024/08/01/edesa-biotech-inc-nasdaqedsa-a-promising-biopharmaceutical-company-advancing-innovative-therapies/
MikeTester - August 2, 2024

RE:EDSA ..... NR this a.m.... up ~ $2...... On watch

EDSA looks very interesting with huge potential, I've initiated a position over the last week or so. looks like not many are onto...
ferret_ca - December 22, 2021

EDSA ..... NR this a.m.... up ~ $2...... On watch

Trading at $9.40 on 2.8 million shares in the Pre-market  No position Watching & waiting
Iseneschal - October 19, 2021
View more Bullboard ››

SKRR Exploration Inc.

SKRR Exploration Inc.

SKRR Exploration Inc. is a Canada-based precious and base metal explorer with properties in Saskatchewan. The Company's ...
View More »